Shengmai Powder regulates alveolar macrophage PPAR-γ and improves the chronic inflammatory state of chronic obstructive pulmonary disease
Allergologia et Immunopathologia · 2024
DOI: 10.15586/aei.v52i5.1135 ↗Kurz gefasst
Fachartikel in der Zeitschrift Allergologia et Immunopathologia, 2024. Verfasst von Dongmei Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, Lianyungang TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Lianyungang, Jiangsu, China. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, PPAR gamma, Drugs, Chinese Herbal, Macrophages, Alveolar. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: COPD
Abstract (Originalsprache)
This study examines the therapeutic effects of Shengmai Powder (SMP) on both in vitro and in vivo models of chronic obstructive pulmonary disease (COPD) and the underlying mechanisms. Cigarette smoke and cigarette extracts were used to create in vitro and in vivo models of COPD. ELISA was used to measure the levels of pro-inflammatory factors (IL-6, TNF-α, and IL-1β) in mouse lung tissue and alveolar macrophages. Flow cytometry assessed the phagocytic capacity of alveolar macrophage. Western blotting was used to analyze the expression of RhoA, PPARγ, IκBα, p-IκBα, P65, and p-P65 in alveolar. The results show that SMP reversed the increased levels of pro-inflammatory factors (IL-6, TNF-α, and IL-1β) in mouse lung tissue and alveolar macrophages induced by cigarette smoke and cigarette extract. SMP also restored the decreased fluorescence intensity and RhoA levels in alveolar macrophages caused by cigarette extract. Additionally, SMP increased PPARγ expression and decreased IκBα and P65 phosphorylation in alveolar macrophages exposed to cigarette extract. Also, the effects of SMP were reversed by PPARγ inhibitors. The study concluded that SMP regulates alveolar macrophage phagocytic function through the PPAR-γ/NF-κB pathway, thereby improving the chronic inflammatory state of COPD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Respiratory Medicine, Lianyungang TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Lianyungang, Jiangsu, China.
- Department of Basic Medicine, Kangda College of Nanjing Medical University, Lianyungang, China.
- Department of Pulmonary and Critical Care Medicine, The Fourth Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China; xy_xu0524@163.com.
Zitieren
APA
Liu, D., Liu, Z., Ma, X., Wang, S., Lin, J., Shi, X., & Xu, X. (2024). Shengmai Powder regulates alveolar macrophage PPAR-γ and improves the chronic inflammatory state of chronic obstructive pulmonary disease. Allergologia et Immunopathologia. https://doi.org/10.15586/aei.v52i5.1135
Vancouver
Liu D, Liu Z, Ma X, Wang S, Lin J, Shi X, et al. Shengmai Powder regulates alveolar macrophage PPAR-γ and improves the chronic inflammatory state of chronic obstructive pulmonary disease. Allergologia et Immunopathologia. 2024. doi:10.15586/aei.v52i5.1135
BibTeX
@article{Liu2024,
author = {Liu, Dongmei and Liu, Zongwei and Ma, Xunxun and Wang, Shengjie and Lin, Jie and Shi, Xiuyan and Xu, Xiaoyong},
title = {Shengmai Powder regulates alveolar macrophage PPAR-γ and improves the chronic inflammatory state of chronic obstructive pulmonary disease},
journal = {Allergologia et Immunopathologia},
year = {2024},
doi = {10.15586/aei.v52i5.1135}
}
EUVIMED